Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

ClinicalTrials.gov ID: NCT05409235

Public ClinicalTrials.gov record NCT05409235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)

Study identification

NCT ID
NCT05409235
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
OcuTerra Therapeutics, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

  • OTT166 Drug
  • Vehicle control Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 28, 2022
Primary completion
Dec 28, 2023
Completion
Dec 28, 2023
Last update posted
Aug 8, 2024

2022 – 2023

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
62
Facility City State ZIP Site status
Clinical Site 123 Peoria Arizona 85381
Clinical Site 150 Phoenix Arizona 85021
Clinical Site 111 Beverly Hills California 90211
Clinical Site 113 Encino California 91436
Clinical Site 138 Fresno California 93720
Clinical Site 129 Huntington Beach California 92647
Clinical Site 121 Pasadena California 91105
Clinical Site 127 Pasadena California 91107
Clinical Site 142 Rancho Cordova California 95670
Clinical Site 116 Riverside California 92505
Clinical Site 125 Sacramento California 95841
CinCor Site 171 Torrance California 90505
Clinical Site 160 Walnut Creek California 94598-5910
Clinical Site 157 Coral Springs Florida 33067
Clinical Site 106 Fort Lauderdale Florida 33309
Clinical Site 131 Jacksonville Florida 32216
Clinical Site 110 Miami Florida 33143
Clinical Site 153 St. Petersburg Florida 33711-1141
Clinical Site 117 Winter Haven Florida 33880
Clinical Site 112 ‘Aiea Hawaii 96701
Clinical Site 146 Oak Forest Illinois 60452
Clinical Site 128 Springfield Illinois 62704
Clinical Site 154 Indianapolis Indiana 46290-1166
Clinical Site 139 Lenexa Kansas 66215
Clinical Site 166 Louisville Kentucky 40206
Clinical Site 167 Metairie Louisiana 70006
Clinical Site 163 Baltimore Maryland 21237
Clinical Site 145 Baltimore Maryland 21287
Clinical Site 103 Hagerstown Maryland 21740
Clinical Site 151 Boston Massachusetts 02111
Clinical Site 104 Boston Massachusetts 02114
Clinical Site 141 Detroit Michigan 48201
Clinical Site 155 Southaven Mississippi 38671
Clinical Site 101 Reno Nevada 89502
Clinical Site 105 Bloomfield New Jersey 07003
Clinical Site 136 Cherry Hill New Jersey 08034
Clinical Site 114 Teaneck New Jersey 07666
Clinical Site 118 Albuquerque New Mexico 87109
Clinical Site 109 Liverpool New York 13088
Clinical Site 162 Rochester New York 14618
Clinical Site 165 Raleigh North Carolina 27587
Clinical Site 143 Beachwood Ohio 44122
Clinical Site 120 Cleveland Ohio 44122
Clinical Site 152 Dublin Ohio 43016
Clinical Site 122 Edmond Oklahoma 73013
Clinical Site 135 Portland Oregon 97239
Clinical Site 158 Springfield Oregon 97477
Clinical Site 115 Kingston Pennsylvania 18704
Clinical Site 130 Beaufort South Carolina 29902
Clinical Site 133 Rapid City South Dakota 57701
Clinical Site 168 Germantown Tennessee 38138
Clinical Site 164 Knoxville Tennessee 37909-2686
Clinical Site 169 Memphis Tennessee 38119
Clinical Site 119 Nashville Tennessee 37203
Clinical Site 161 Austin Texas 78705
Clinical Site 102 Bellaire Texas 77401
Clinical Site 108 Bellaire Texas 77401
Clinical Site 147 Burleson Texas 76028
Clinical Site 132 Fort Worth Texas 76104
Clinical Site 156 Houston Texas 77025
Clinical Site 126 McAllen Texas 78503
Clinical Site 140 San Antonio Texas 78240-1375
Clinical Site 137 San Antonio Texas 78240
Clinical Site 144 Texas City Texas 78240
Clinical Site 159 Lynchburg Virginia 24502
Clinical Site 149 Seattle Washington 98125
Clinical Site 148 Spokane Washington 98204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05409235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05409235 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →